Daily Cancer News

OMNI Health Media is a leading online provider of Daily Cancer News. OMNI’s Daily Cancer News provides summaries of new treatment strategies as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating cancer therapies and supportive care strategies, to better educate patients and their caregivers, ensuring timely access to the best cancer care available.

CancerConnect Cancer Commuity & Discussions


Latest Cancer News

FDA Approves Opdivo for Renal Cell Carcinoma (November 25, 2015)

The FDA granted approval to nivolumab (Opdivo) for patients with renal cell carcinoma. Opdivo, a PD-1 inhibitor, was previously approved for the treatment of melanoma whose tumors express the BRAF V600... Continue Reading

Do You Have Heartburn or GERD? (November 24, 2015)

GERD Awareness Week is November 22 – 28, 2015 and takes place each year during the week of Thanksgiving.   GERD is a common disorder that occurs when the contents of the stomach repeatedly flow back... Continue Reading

Long-Term Survival Benefit Demonstrated with RINTEGA® in Recurrent Glioblastoma (November 24, 2015)

Mature survival data from a randomized, double-blind Phase 2 clinical study evaluating RINTEGA® (rindopepimut) in patients with EGFRvIII-positive, recurrent glioblastoma (GBM) were recently presented... Continue Reading

Ninlaro® Approved for Multiple Myeloma (November 23, 2015)

The United States Food and Drug Administration (FDA) has granted approval to Ninlaro® (ixazomib) for the treatment of multiple myeloma. This marks the third drug approved this year for the treatment of... Continue Reading

Novel Precision Medicine Tagrisso Approved for Treatment of Lung Cancer (November 19, 2015)

The United States Food and Drug Administration (FDA) has approved Tagrisso (osimertinib) for the treatment of lung cancer with the epidermal growth factor receptor (EGFR) T790M mutation. The indication... Continue Reading

Zydelig® Combined with Treanda and Rituxan Appears Promising in Treatment of Chronic Lymphocytic Leukemia (November 18, 2015)

Following the recommendation by an independent Data Monitoring Committee (DMC), Gilead Sciences, Inc today announced that its Phase 3 clinical study evaluating Zydelig® (idelalisib) added to standard... Continue Reading

November is National Pancreatic Cancer Awareness Month (November 17, 2015)

Copyright © 2015 CancerConnect. All Rights Reserved. Read More →

FDA Approves Darzalex Providing a New Treatment for Patients with Multiple Myeloma (November 17, 2015)

Today the U.S. Food and Drug Administration granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma. Darzalex is the first monoclonal antibody approved for treating... Continue Reading

Does Processed Meat Cause Colorectal Cancer? (November 16, 2015)

According to the International Agency for Research on Cancer (IARC), eating processed meat products can increase a person’s risk for developing colorectal cancer. Processed meat is classified as meat... Continue Reading

GBM AGILE: A Next-Generation Clinical Trial for Brain Cancer (November 13, 2015)

Glioblastoma Multiforme (GBM) is a devastating disease. The deadliest and most aggressive form of brain tumor, GBM is expected to claim the lives of 12,000 people in the United States this year, plus tens... Continue Reading

New Lab Test Enables Precision Treatment for Lung Cancer (November 13, 2015)

The complementary laboratory test that measures PD-L1 levels among patients with lung cancer who are to receive treatment with Opdivo® (nivolumab), is now available for commercial use and can help guide... Continue Reading

National “Check Yourself to Protect Yourself ALL YEAR” Campaign Highlights Need for Year-Round Skin Cancer Prevention (November 12, 2015)

Although one in five Americans will get skin cancer in their lifetimes, 65 percent of people of color don’t believe they are at risk and face lower survival rates as a result. To change these odds,... Continue Reading

Updated Results Confirm Improved Survival with Opdivo® in Lung Cancer (November 10, 2015)

Longer follow-up confirms the survival benefit with the use of the PD-1 inhibitor, Opdivo® (nivolumab), compared to the chemotherapy agent, docetaxel, among patients with recurrent non-small cell lung... Continue Reading

Yervoy Gets Expanded Approval for Earlier-Stage Melanoma (November 9, 2015)

The United States Food and Drug Administration (FDA) has expanded the approval indication for Yervoy (ipilimumab) to include treatment of stage III melanoma. Melanoma is the most deadly form of skin cancer,... Continue Reading

Shorter Course of Radiation as Effective as Longer Course in Low-Risk Prostate Cancer (November 5, 2015)

A shorter course of hypofractionated radiation therapy, a treatment in which larger doses of radiation are delivered over a shorter time period than conventional radiation, appears as effective as longer... Continue Reading

Combined Hormone and Radiation Therapy Superior to Radiation Alone for Prostate Cancer Recurring After Prostatectomy (November 4, 2015)

The addition of two years of anti-androgen therapy (AAT) to radiation therapy reduces the risk of death caused by prostate cancer among men treated for a recurrence following a prostatectomy. Treatment... Continue Reading

The National Consortium of Breast Centers (NCBC) on American Cancer Society’s Breast Cancer Screening Recommendations (November 3, 2015)

The American Cancer Society (ACS) released their new guidelines last week recommending screening mammograms begin for women at age 45, and biennial screenings beginning at age 55. Other respected medical... Continue Reading

Onivyde Approved for Pancreatic Cancer (November 3, 2015)

The United States Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection) to be used in combination with fluorouracil and leucovorin for patients with advanced pancreatic cancer. The... Continue Reading

More Cancer News

CancerConnect Cancer Commuity & Discussions

Cancer Types

Headline News by Cancer Type

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS